DLCO declined earliest, falling measurably about 10 years before the defined onset. By five years before onset, DLCO had ...

Clinical worsening also occurred less frequently with treprostinil ...

The complex and redundant biology underlying fibrosis is widely believed to contribute to the limited effectiveness of single-target approaches. “Fibrosis is a biologically complex, organ-specific ...

PPF is identified by decline in lung function, worsening symptoms, and increased fibrosis on imaging, with variable criteria across studies. Risk factors for PPF include older age, male sex, smoking, ...

Type 2 diabetes and prediabetes can both significantly impact pulmonary health, highlighting the need for early detection and intervention. A new paper has highlighted the significant impact of type 2 ...

Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...

St. Luke’s University Health Network has been designated as a Care Center within the Pulmonary Fibrosis Foundation’s nationally recognized Care Center Network, expanding access to specialized care ...

The Pulmonary Fibrosis Foundation's Care Center Network has grown to include 96 sites in 40 states as part of its first expansion since 2023, marking a milestone in strengthening access to ...

Most of Dedra’s life was spent on the sidelines. She was diagnosed with cystic fibrosis – an inherited condition that causes mucus buildup in the lungs, and often leads to infections and damage to ...

Cystic fibrosis is one of the most common genetic disorders, causing thick mucus build-up in the lungs and other parts of the body, breathing problems, and infection. A three-drug cocktail known as ...